Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LIG1 | P18858 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2919005 | 0.81 | — | — | |
| SCHEMBL2922297 | 0.79 | MAPT (0.31) | MAPT | |
| SCHEMBL2916414 | 0.78 | — | — | |
| SCHEMBL2916144 | 0.78 | — | — | |
| SCHEMBL5085695 | 0.77 | ALDH1A1 (0.37) | ALDH1A1HPGDTSHRMAPK1HSD17B10 | |
| SCHEMBL2922068 | 0.77 | — | — | |
| SCHEMBL2921120 | 0.75 | — | — | |
| SCHEMBL2918495 | 0.74 | — | — | |
| SCHEMBL2919827 | 0.73 | — | — | |
| SCHEMBL2919107 | 0.71 | CNR1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1475383-B1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | SUMITOMO CHEMICAL CO (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-7241927-B2 | Transition metal complexes, ligands, catalysts for olefin polymerization, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-10 | — | — | US | disclosed |
| US-7141690-B2 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060111525-A1 | Transition metal complexes, ligands, catalysts for olefin polymerization, and process for production of olefin polymers | HANAOKA HIDENORI | 2006-05-25 | — | — | US | disclosed |
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1475383-A1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | Sumitomo Chemical Company, Limited (JP) | 2004-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | PYM1, OR10J3, AP1M1 | ALDH1A1 2570/4885HPGD 2864/4885TSHR 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.